← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2010Last known activity
May 26, 2019
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 3 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (7)
- NCT04028466Lead sponsorPhase 4May 26, 2019
- NCT04028466Reponsible party - principal investigatorPhase 4May 26, 2019
- NCT04313868Overall official - principal investigatorPhase 1Jun 13, 2014
- NCT01486706Sponsor investigatorPhase 2/Phase 3Oct 1, 2010
- NCT01486706CollaboratorPhase 2/Phase 3Oct 1, 2010
- NCT01486706Study directorPhase 2/Phase 3Oct 1, 2010
- NCT01486706Lead sponsorPhase 2/Phase 3Oct 1, 2010
Details
- Last known activity
- May 26, 2019